Recruitment is underway in Cambridge for volunteers to take part in clinical trials of a revolutionary new needle-free vaccine to protect against SARS-CoV-2 –
Semarion Ltd, a University of Cambridge spin-out company from the Cavendish Laboratory, combines materials engineering and cell biology to help biopharma
Zero-carbon refrigeration pioneer Barocal has secured a £1.3 million investment to accelerate commercialisation of its novel technology designed to cut global
Connect: Health Tech, the University of Cambridge Enterprise Zone, has today launched a roadmap, ‘Creating a University Enterprise Zone for Cambridge across
A new rapid diagnostic test for COVID-19, developed by a University of Cambridge spinout company and capable of diagnosing the infection in under 90 minutes, is being deployed at Cambridge hospitals, ahead of being launched in hospitals nationwide.
A team of UK scientists have identified the mechanism behind hardening of the arteries, and shown in animal studies that a generic medication normally used to treat acne could be an effective treatment for the condition.
Scientists at the University of Cambridge have developed a new test that can reliably predict the future course of inflammatory bowel disease in individuals, transforming treatments for patients and paving the way for a personalised approach.
A recent University of Cambridge spin-out company, Paragraf, has started producing graphene – a sheet of carbon just one atomic layer thick – at up to eight inches (20cm) in diameter, large enough for commercial electronic devices.
/
2
